There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Neuraminidase (NA)

Neuraminidase (NA)

Neuraminidase (NA) Molecule Information

Target Synonym:Neuraminidase
Number of Launched Drugs:4
Number of Drugs in Clinical Trials:2
Lastest Research Phase:Approved

Neuraminidase (NA) Protein Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
NEE-V5243 Influenza Influenza A[A/swine/Jiangsu/J004/2018(H1N1)] Neuraminidase (NA) Protein, His Tag
H54-V5247 Influenza Influenza A [A/Thailand/1(KAN-1)/2004 (H5N1)] Neuraminidase (NA) Protein, His Tag

Neuraminidase (NA) Molecule Synonym Name


Neuraminidase (NA) Molecule Background

Neuraminidase (NA) and hemagglutinin (HA) are major membrane glycoproteins found on the surface of influenza virus. Hemagglutinin binds to the sialic acid-containing receptors on the surface of host cells during initial infection and at the end of an infectious cycle. Neuraminidase, on the other hand, cleaves the HA-sialic acid bondage from the newly formed virions and the host cell receptors during budding. Neuraminidase thus is described as a receptor-destroying enzyme which facilitates virus release and efficient spread of the progeny virus from cell to cell.

Neuraminidase (NA) References

Neuraminidase (NA) Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Oseltamivir Phosphate GS-4104; EN-241104; RO-640796; Ro-64-0796; GS-4104-002; GS-4104/002; RO-640796/002 Approved F. Hoffmann-La Roche Ltd 达菲, Tamiflu, Hanmi Flu EU Influenza, Human s:23:"Roche Registration Gmbh"; 1999-09-21 Influenza A virus infections; Influenza, Human; Kidney Failure, Chronic Details
Laninamivir Octanoate Hydrate CS-8958; R-118958 Approved Daiichi Sankyo Co Ltd Inavir Japan Influenza B virus infection; Influenza A virus infections s:21:"Daiichi Sankyo Co Ltd"; 2010-09-10 Influenza A virus infections; Influenza, Human; Asthma; Influenza B virus infection Details
Zanamivir GG-167; GR-121167; GR-121167X; 4-Guanidino-Neu5Ac2en Approved Glaxosmithkline Plc 依乐韦, Relenza EU Influenza, Human s:36:"Glaxosmithkline Trading Services Ltd"; 1999-07-26 Orthomyxoviridae Infections; Influenza, Human Details
Peramivir Hydrate JNJ-2; BCX-1812; S-021812; RWJ-270201 Approved Biocryst Pharmaceuticals 力纬, Alpivab, Rapivab, Rapiacta, Peramiflu United States Influenza, Human s:28:"Biocryst Pharmaceuticals Inc"; 2010-01-13 Headache; Cough; Myalgia; Influenza A virus infections; Fatigue; Musculoskeletal Pain; Influenza, Human; Fever; Arthralgia; Nasal Obstruction; Pharyngitis Details

Neuraminidase (NA) Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
HNC042 HNC-042 Phase 1 Clinical Guangzhou Henovcom Bioscience Co Ltd Influenza A virus infections; Influenza, Human; Influenza B virus infection Details
Oseltamivir/Pimodivir Phase 1 Clinical Johnson & Johnson Influenza A virus infections Details

This web search service is supported by Google Inc.